All Articles

Verastem Oncology's combo therapy posts impressive early data in a notoriously deadly cancer, revealing a shrewd strategy for tackling drug resistance.

With a promising drug and a fortified war chest, Trevi Therapeutics’ upcoming conference tour is a calculated move to conquer a vast, unmet medical need.

A landmark grant and trial expansion signal a pivotal shift in Parkinson's research, blending genetic targeting, global collaboration, and digital health.

XCharge's new C7 charger boasts record power, but its real test lies in winning public trust. A deep dive into the tech, strategy, and partnerships redefining speed.

As ad tech firm Swivel staffs up with industry veterans, it's not just building a company—it's signaling the ad industry's shift from AI hype to execution.

With a new $400M debt facility, Dyne Therapeutics is accelerating two promising drugs for DMD and DM1, showcasing the power of strategic, non-dilutive financing.

As Terry Duffy moves to Executive Chairman, Lynne Fitzpatrick prepares to lead CME. This isn't just succession; it's a calculated move for a new digital era.

A new low-risk trial program for hybrid vehicles reveals China's pragmatic strategy to win over markets where pure EVs can't yet compete.

Three of Europe's largest steelmakers warn the EU's climate policy could gut manufacturing. Is this a genuine crisis or a last-ditch bid to delay the inevitable?

Gene therapy firm uniQure plans a 2026 FDA submission for AMT-130, a potential first disease-modifying treatment for Huntington's, on an accelerated track.

For the second year, Kuveyt Türk's academy wins a top global award. We look inside the operational innovation driving its success: an AI-powered talent engine.

New research reveals that custom 3D braces can actively correct spinal curves, not just prevent them from worsening. This paradigm shift in non-surgical care offers new hope.

21 doctors from one practice in a "Top Doctors" Hall of Fame is a headline. But what does it reveal about building trust and innovation in cancer care?

Beyond a simple summer promotion, the renewed Oatly-Nespresso pact reveals a calculated strategy to conquer the future of coffee—a future that is cold, plant-based, and highly profitable.

Albertsons Media Collective and P&G are ditching ads for scripted dramas, using shopper data to create entertainment. Is this the future of retail media?

Yardi's new connector fuses its vast Matrix dataset with Anthropic's AI, enabling real-time, portfolio-wide analysis that was once the stuff of sci-fi.

A new report reveals 99% of advertisers see curation as vital, yet most fail to execute it effectively, fueling a crisis of transparency and wasted spend.

A new $500k fund and a major US grant signal a strategic shift in Canadian journalism. Is this philanthropic model the key to empowering new voices?

Developer Rosehaven Homes doubles down on Simcoe County, launching two major projects to capture the GTA exodus. But can it balance rapid growth with local needs?

The latest housing report shows buyers are back, but sellers are staying put. This supply squeeze is creating a complex, competitive landscape across the U.S.